Central nervous system damage due to acute paraquat poisoning: A neuroimaging study with 3.0T MRI

NeuroToxicology

Volumn 33, Issue 5, 2012, Pages 1330-1337

  Wu, Bailin ^a   Song, Bo ^a   Tian, Suzhai ^a   Huo, Shuhua ^a   Cui, Caixia ^a   Guo, Yansu ^a,b   Liu, Huaijun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Neurological Key Laboratory of Hebei Province   (China)

Author keywords

Central nervous system; Diffusion tensor imaging; Hemorrhage; Iron; MRI; Paraquat

Indexed keywords

IRON; PARAQUAT;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; EXTRAPYRAMIDAL SYSTEM; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAQUAT POISONING; PRIORITY JOURNAL; SCHOOL CHILD; SUICIDE ATTEMPT; SURVIVOR; SUSCEPTIBILITY WEIGHTED IMAGING; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM; CHILD; FEMALE; HERBICIDES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROTOXICITY SYNDROMES; PARAQUAT; RETROSPECTIVE STUDIES; YOUNG ADULT;

ANIMALIA;

EID: 84867234462     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.08.007     Document Type: Article

References (45)

1. Beaulieu C., Allen P.S. Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn Reson Med 1994, 32:579-583.
2. Bonneh-Barkay D., Langston W.J., Di Monte D.A. Toxicity of redox cycling pesticides in primary mesencephalic cultures. Antioxid Redox Signal 2005, 7:649-653.
3. Chang Y., Woo S.T., Lee J.J. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Neurotoxicology 2009, 30:950-957.
4. Cocheme H.M., Murphy M.P. Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 2008, 283:1786-1798.
5. Courchesne E., Chisum H.J., Townsend J., Cowles A., Covington J., Egaas B., et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000, 216:672-682.
6. De Souza J.M., Domingues R.C., Cruz L.H., Domingues F.S., Iasbeck T., Gasparetto E.L. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations; a comparison with T2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 2008, 29:154-158.
7. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res 1982, 17:319-334.
8. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hänicke W., Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo, relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989, 11:47-63.
9. Francesca C., Nicolas L., Antoine R.T., Martine S.P., Lincoln J., Brooks W.F., et al. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Gross Neurobiol Dis 2005, 20:360-371.
10. Geert D.G., Marleen V., Vincent V.M., Ilse T., Alexander L., Annemie V.L. In vivo diffusion tensor imaging (DTI) of brain subdivisions and vocal pathways in songbirds. NeuroImage 2006, 29:754-763.
11. Grant H., Lantos P.L., Parkinson C. Cerebral damage in paraquat poisoning. Histopathology 1980, 4:185-195.
12. Haacke E.M., Ayaz M., Khan A., Manova E.S., Krishnamurthy B., Gollapalli L., et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007, 26:256-264.
13. Haacke E.M., Cheng N.Y.C., House M.J., Liu Q., Neelavalli J., Ogg R.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. J Magn Reson Imaging 2005, 23:1-25.
14. Hopp K., Popescu B.F.G., McCrea R.P.E., Harder S.L., Robinson C.A., Haacke M.E., et al. Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence. J Magn Reson Imaging 2010, 31:1346-1354.
15. Hoptman M.J., Nierenberg J., Bertisch H.C., Catalano D., Ardekani B.A., Branch C.A., et al. A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophr Res 2008, 106:115-124.
16. Hughes J.T. Brain damage due to paraquat poisoning: a fatal case with neuropathological examination of the brain. Neurotoxicology 1988, 9:243-338.
17. Hutchinson M., Raff U. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. Am J Neuroradiol 2000, 21:697-701.
18. Kakhlon O., Cabantchik Z.L. The labil iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 2002, 33:1037-1046.
19. Lan J., Jiang D.H. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration inmice. J Neural Transm 1997, 104:469-481.
20. Lee Mosley R., Benner E.J., Kadiu I., Thomas M., Boska M.D., Hasan K., et al. Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease. Clin Neurosci Res 2006, 6:261-281.
21. Lin A., Nguy C.H., Shic F., Ross B.D. Accumulation of methylsul-fonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett 2001, 123:169-177.
22. Martin W.R., Wieler M., Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008, 70:1411-1417.
23. McCormack A.L., Thiruchelvam M., Manning-Bog A.B., Thiffault C., Langston J.W., Cory-Slechta D.A., et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 2002, 10:119-127.
24. McCormack A.L., DiMonte D.A. Effects of l-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J Neurochem 2003, 85:82-86.
25. Michaeli S., Oz G., Sorce D.J., Garwood M., Ugurbil K., Majestic S., et al. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord 2007, 22:334-340.
26. Mittal S., Wu Z., Neelavalli J., Haacke E.M. Susceptibility-weighted imaging: technical aspects and clinical applications. Part 2. Am J Neuroradiol 2009, 30:232-252.
27. Ortiz-Ortiz M.A., Morán J.M., Ruiz-Mesa L.M., Bonmatty R.G., Fuentes J.M. Protective effect of the glial cell line-derived neurotrophic factor (GDNF) on human mesencephalic neuron-derived cells against neurotoxicity induced by paraquat. Environ Toxicol Pharmacol 2011, 31:129-136.
28. Parka J., Ohyashikib K., Akataa S., Takaraa K., Unoa R., Kakizakia D., et al. Evaluation of cardiac iron overload in transfusion-dependent adult marrow failure patients by magnetic resonance imaging. Leuk Res 2009, 33:756-758.
29. Patel S., Sinha A., Singh M.P. Brief communication Identification of differentially expressed proteins in striatum of maneb and paraquat induced Parkinson's disease phenotype in mouse. Neurotoxicol Teratol 2007, 29:578-585.
30. Petrovitch H., Ross G.W., Abbot R.D., Sanderson W.T., Sharp D.S., Tanner C.M., et al. Plantation work and risk of Parkinson's disease in a population-based longitudinal study. Arch Neurol 2002, 59:1787-1792.
31. Pfeffethaurn A., Sullivan E.V. Inereased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn Reson Med 2003, 49:953-961.
32. Pfefferbaum A., Adalsteinsson E., Rohlfing T., Sullivan E.V. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 2009, 47:493-500.
33. Qian Z.M., Shen X. Brain iron transport and neurodegeneration. Trends Mol Med 2001, 7:103-108.
34. Rasalkara D.D., Chua W.C., Cheungb K.L., Yeunga D.K. Magnetic resonance changes with spectroscopy and diffusion tensor imaging after acute cyanide poisoning in a child. Eur J Radiol 2010, 73(Extra):e5-e8.
35. Rauscher A., Sedlacik J., Barth M., Mentzel H.J., Reichenbach J.R. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005, 26:736-742.
36. Rauscher A., Sedlacik J., Fitzek C., Walter B., Hochstetter A., Kalff R. High resolution susceptibility weighted MR-imaging of brain tumors during the application of a gaseous agent. Rofo 2005, 177:1065-1069.
37. Sehgal V., Delproposto Z., Haddar D., Haacke E.M., Sloan A.E., Zamorano L.J., et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006, 24:41-51.
38. Sehgal V., Delproposto Z., Haacke E.M., Tong K.A., Wycliffe N., Kido D.K., et al. Clinical application of neuroimaging with susceptibility weighted imaging. J Magn Reson Imaging 2005, 22:439-450.
39. Shi J., Gao Y.F., Huang P., Zeng R.S. Clinical analysis of multiple organ dysfunction syndrome caused by acute paraquat poisoning. Chin J Ind Hygiene Occup Dis 2011, 29:519-521.
40. Soontornniyomkij V., Bunyaratvej S. Fatal paraquat poisoning: a light microscopic study in eight autopsy cases. J Med Assoc Thai 1992, 75(Suppl. 1):98-105.
41. Srivastava G., Dixit A., Yadav S., Patel D.K., Prakash O., Singh M.P. Resveratrol potentiates cytochrome P450 2d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med 2012, 52:1294-1306.
42. Tian Y.P., Su J.L., Gao H.B., Tong F., Chen H., Shi H.W., et al. Treatment strategies for 113 cases with acute paraquat poisoning. Chin J Crit Care Med 2006, 26:542-543.
43. Tomenson J.A., Campbell C. Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: a retrospective cohort study. BMJ Open 2011, 2:e000283.
44. 1H-MRS. Chin J Med Imaging Technol 2010, 26:1833-1836.
45. Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004, 5:863-873.